In the latest in an ongoing series of quarterly briefings looking at major (and some minor) developments in the world of tobacco, we assess the latest performance of the major multinationals, provide cannabis and NPD/NGP updates, and review economic growth projections for the world’s key markets and what to look for in the next quarter.
The US FDA announced in September 2020 that it will make public the list of tobacco products subject to its 9 September deadline and that have filed applications to remain on the market, in order to help customers and retailers identify illegal products easily. All products with applications filed before the deadline have a one-year grace period to stay on the market while the review takes place, unless the FDA rejects the request. The publication date is unknown, and the FDA has advised retailers to monitor the press releases issued by various manufacturers announcing the submission of applications, while trade organisations recommend that they approach manufacturers directly to confirm the submission.
The California Assembly approved in August 2020 a ban on the retail sale of flavoured tobacco products, with the aim of reducing smoking and vaping by users attracted by flavours that include fruit and menthol. The ban includes retail sales of flavoured products including cigarettes, many cigars and chewing tobacco, as well as electronic cigarettes and flavoured vaping products, whereas hookah products, premium cigars and some pipe tobacco were exempted.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page